Theravasc Inc:製薬・医療:M&Aディール及び事業提携情報

◆英語タイトル:Theravasc Inc - Pharmaceuticals & Healthcare - Deals and Alliances Profile
◆商品コード:DATA904C2801
◆発行会社(調査会社):GlobalData
◆発行日:2018年8月
◆ページ数:16
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:アメリカ
◆産業分野:製薬・医療
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD250 ⇒換算¥37,000見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD500 ⇒換算¥74,000見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD750 ⇒換算¥111,000見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Summary
Theravasc Inc (Theravasc) is a pharmaceutical company that develops treatments for various chronic medical diseases using oral formulation of sodium nitrite. The company’s product includes TV1001SR, a coated oral formulation of sodium nitrite for the treatment of peripheral artery diseases and diabetic neuropathy. Its TV1001SR is non-addicting, non-sedating, and has a mechanism of action to treat pain. Theravasc conducts research programs in peripheral artery diseases, aging and wound healing. It develops sodium nitrite as a therapeutic to increase motor and cognitive function while reducing oxidative stress. The company’s product with sodium nitrite is referenced to stimulate the re-growth of blood vessels in ischemic tissues. Theravasc is headquartered in Cleveland, Ohio, the US.

Theravasc Inc – Pharmaceuticals & Healthcare – Deals and Alliances Profile provides you comprehensive data and trend analysis of the company’s Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Pharma eTrack deals database, and primary and secondary research.

Scope

- Financial Deals – Analysis of the company’s financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year – Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type – Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region – Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector – Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals – Information on the company’s major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.
- Business Description – A brief description of the company’s operations.
- Key Employees – A list of the key executives of the company.
- Important Locations and Subsidiaries – A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors – A list of the key competitors of the company.
- Key Recent Developments – A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company’s financial deals that enable you to understand the company’s expansion/divestiture and fund requirements
- The profile enables you to analyze the company’s financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company’s business segments’ expansion / divestiture strategy
- The profile presents deals from the company’s core business segments’ perspective to help you understand its corporate strategy.

Access elaborate information on the company’s recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company’s key financial metrics and ratios.

Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

【レポートの目次】

Table of Contents
Table of Contents 3
List of Tables 4
List of Figures 4
Theravasc Inc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
Theravasc Inc, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6
Theravasc Inc, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
Theravasc Inc, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 8
Theravasc Inc, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 9
Theravasc Inc, Pharmaceuticals & Healthcare, Deal Details 10
Venture Financing 10
Theravasc Secures Venture Funding from Rev1 Ventures 10
Theravasc Raises USD0.4 Million in Venture Financing 11
Theravasc Raises US$0.2 Million In Venture Financing 12
Theravasc Inc – Key Competitors 13
Theravasc Inc – Key Employees 14
Theravasc Inc – Locations And Subsidiaries 15
Head Office 15
Appendix 16
Methodology 16
About GlobalData 16
Contact Us 16
Disclaimer 16

List of Tables
Theravasc Inc, Pharmaceuticals & Healthcare, Key Facts 2
Theravasc Inc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
Theravasc Inc, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6
Theravasc Inc, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
Theravasc Inc, Deals By Therapy Area, 2012 to YTD 2018 8
Theravasc Inc, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 9
Theravasc Secures Venture Funding from Rev1 Ventures 10
Theravasc Raises USD0.4 Million in Venture Financing 11
Theravasc Raises US$0.2 Million In Venture Financing 12
Theravasc Inc, Key Competitors 13
Theravasc Inc, Key Employees 14

List of Figures
Theravasc Inc, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 2
Theravasc Inc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 2
Theravasc Inc, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 2
Theravasc Inc, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 2
Theravasc Inc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
Theravasc Inc, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 6
Theravasc Inc, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
Theravasc Inc, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 8

★海外企業調査レポート[Theravasc Inc:製薬・医療:M&Aディール及び事業提携情報]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • Penn National Gaming Inc:企業のM&A・事業提携・投資動向
    Penn National Gaming Inc - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's Penn National Gaming Inc Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mergers and acquisiti …
  • Randgold Resources Limited:企業の戦略・SWOT・財務情報
    Randgold Resources Limited - Strategy, SWOT and Corporate Finance Report Summary Randgold Resources Limited - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and servi …
  • BiosanaPharma BV:製薬・医療:M&Aディール及び事業提携情報
    Summary BiosanaPharma BV (Biosana) is a biotechnology company engaged in the development of monoclonal antibody biologicals (mAbs), biosimilars and biobetters. Its pipeline products include BP001: biosimilar of Omalizumab (anti-allergy); BP002: biosimilar of Denosumab (anti-osteoporosis); BOX001: or …
  • BRS Aerospace:企業の戦略・SWOT・財務分析
    BRS Aerospace - Strategy, SWOT and Corporate Finance Report Summary BRS Aerospace - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate …
  • DiaMedica Therapeutics Inc (DMA):企業の財務・戦略的SWOT分析
    Summary DiaMedica Therapeutics Inc (DiaMedica) formerly DiaMedica Inc, is a clinical-stage bio pharmaceutical company which develops innovative medicines for the treatment neurological and kidney diseases. Its lead product candidate DM-199, is a human recombinant protein that treats diabetes type 1 …
  • Organogenesis Inc:医療機器:M&Aディール及び事業提携情報
    Summary Organogenesis Inc (Organogenesis) is a regenerative medicine company that operates in the areas of bioactive wound healing and soft tissue regeneration. The company’s products include apligraf and dermagraft. Its dermagraft is used for the treatment of full-thickness diabetic foot ulcers. Or …
  • Thermax Ltd (THERMAX):企業の財務・戦略的SWOT分析
    Thermax Ltd (THERMAX) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and …
  • InspireMD Inc (NSPR):企業の財務・戦略的SWOT分析
    Summary InspireMD Inc (InspireMD) is a medical device company that develops and commercializes embolic prevention systems and neurovascular devices. The company offers CGuard carotid embolic prevention systems for use in carotid artery applications; and MGuard prime embolic protection systems for us …
  • Edison SpA (EDNR):電力:M&Aディール及び事業提携情報
    Summary Edison SpA (Edison), a subsidiary of Electricite de France S.A., is an energy company that explores, produces, develops and sells natural gas and crude oil in the Mediterranean Basin. The company generates and sells electricity; and develops, stores, transports and sells gas in Italy. Edison …
  • NTPC Ltd (NTPC):電力:M&Aディール及び事業提携情報
    Summary NTPC Ltd (NTPC) is a Public sector undertaking energy conglomerate. It has presence in the entire value chain of the power generation business. The company produces electricity and sells that to state power utilities on wholesale basis. NTPC generates power using coal, gas, liquid fuel and h …
  • Shanghai Pudong Development Bank Co., Ltd.:企業の戦略・SWOT・財務情報
    Shanghai Pudong Development Bank Co., Ltd. - Strategy, SWOT and Corporate Finance Report Summary Shanghai Pudong Development Bank Co., Ltd. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, …
  • WGL Holdings Inc (WGL):企業の財務・戦略的SWOT分析
    WGL Holdings Inc (WGL) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses an …
  • Huons Global Co Ltd (084110):企業の財務・戦略的SWOT分析
    Huons Global Co Ltd (084110) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknes …
  • Alabama Power Co:発電所・企業SWOT分析
    Alabama Power Co - Power Plants and SWOT Analysis, 2017 Update Summary The report contains a detailed description of the power generation company’s business operations, history, corporate strategy, and business structure. This report contains a detailed SWOT analysis, information on key employees (e …
  • Tivoli A/S:企業の戦略・SWOT・財務分析
    Tivoli A/S - Strategy, SWOT and Corporate Finance Report Summary Tivoli A/S - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate actio …
  • VeriSign Inc (VRSN):企業の戦略的SWOT分析
    VeriSign Inc (VRSN) - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and se …
  • Cytogel Pharma LLC-製薬・医療分野:企業M&A・提携分析
    Summary Cytogel Pharma LLC (Cytogel Pharma) is a biopharmaceutical development company that provides platform technologies and product candidates. The company offers novel analgesic product candidates and polymer and hydrogel drug delivery platform technologies. Its analgesic product candidates offe …
  • Epcor Utilities Inc:企業の発電所・SWOT分析2018
    Epcor Utilities Inc - Power Plants and SWOT Analysis, 2018 Update Summary The report contains a detailed description of the power generation company’s business operations, history, corporate strategy, and business structure. This report contains a detailed SWOT analysis, information on key employees …
  • Blue Coat Systems, Inc.:企業のM&A・事業提携・投資動向
    Blue Coat Systems, Inc. - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's Blue Coat Systems, Inc. Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mergers and acquisition …
  • W. L. Gore & Associates Inc:企業の戦略的SWOT分析
    W. L. Gore & Associates Inc - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major product …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆